| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.85B | 56.54B | 53.92B | 52.77B | 48.60B | 49.06B |
| Gross Profit | 9.19B | 10.68B | 9.35B | 9.28B | 6.20B | 8.54B |
| EBITDA | 7.02B | 8.08B | 7.34B | 7.73B | 4.82B | 6.68B |
| Net Income | 2.59B | 923.13M | 2.95B | 1.77B | 788.00M | 2.84B |
Balance Sheet | ||||||
| Total Assets | 45.79B | 48.80B | 44.89B | 46.36B | 43.06B | 42.94B |
| Cash, Cash Equivalents and Short-Term Investments | 8.39B | 11.31B | 7.98B | 5.20B | 3.71B | 2.98B |
| Total Debt | 508.83M | 640.92M | 580.35M | 2.39B | 5.15B | 7.02B |
| Total Liabilities | 19.07B | 19.51B | 18.25B | 21.70B | 22.51B | 24.24B |
| Stockholders Equity | 26.70B | 29.25B | 26.64B | 24.66B | 20.55B | 18.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.27B | 4.99B | 4.41B | 2.99B | 3.24B |
| Operating Cash Flow | 0.00 | 6.44B | 7.18B | 6.56B | 5.24B | 5.44B |
| Investing Cash Flow | 0.00 | -2.69B | -2.29B | -2.11B | -2.45B | -1.63B |
| Financing Cash Flow | 0.00 | -630.34M | -2.10B | -3.03B | -2.10B | -3.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥11.18B | 6.74 | ― | 3.90% | -0.27% | 469.27% | |
71 Outperform | ¥14.91B | 18.30 | ― | 1.67% | 4.87% | -68.74% | |
65 Neutral | ¥18.46B | 7.15 | ― | 2.70% | -7.62% | 21.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥24.79B | 24.22 | ― | 4.20% | 0.41% | -59.51% | |
53 Neutral | ¥25.36B | 15.79 | ― | 3.33% | -0.09% | 106.66% | |
52 Neutral | ¥17.73B | 9.98 | ― | 3.19% | -1.17% | ― |